Morgan Hanger is the Executive Director of the Clinical Trials Transformation Initiative (CTTI), a public-private partnership between Duke University and the U.S. Food and Drug Administration. She brings extensive experience in convening diverse stakeholders to tackle complex challenges in evidence generation and is deeply committed to data ethics and transparency. 

Ms. Hanger has held leadership roles at health technology companies focused on improving patient experiences—streamlining specialty product access, simplifying Medicare plan selection, and advancing learning through data sharing. As Vice President at PatientsLikeMe, she led initiatives to integrate patient-generated health data into life sciences and regulatory settings, developing tools to enhance clinical trial design and support decentralized trials. Prior to that, she advised biotech and pharmaceutical organizations on research strategies at Avalere Health. 

Ms. Hanger also contributed to health outcomes research at Memorial Sloan Kettering Cancer Center, with a focus on equity and cost in oncology, and conducted policy analysis at the Congressional Budget Office on federally supported comparative effectiveness research. 

Ms. Hanger holds a Bachelor of Arts in Politics, summa cum laude, from New York University and a Master of Public Policy from the University of California, Berkeley. She is passionate about fostering collaboration to drive meaningful improvements in clinical research.